Global Nitric Oxide Therapy Device 麻豆原创 Growth 2025-2031

Publication ID:

LPI06259521

Publication Date:

June 11, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Nitric Oxide Therapy Device market size is predicted to grow from US$ 40.6 million in 2025 to US$ 57.6 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.
Nitric oxide therapy device, also called nitric oxide inhalation therapy device, is a medical device that inhales nitric oxide (NO) to patients to treat diseases.
Clinically, nitric oxide therapy devices are generally used in conjunction with ventilators to treat pulmonary hypertension, respiratory failure, acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), high altitude pulmonary edema (HAPE), Acute pneumonia, acute pulmonary embolism, bronchial asthma, inhalation lung injury and other diseases, the applicable group includes newborns, children, and adults. It can improve the arterial pressure, ventilation capacity, and oxygenation capacity of the patient"s lungs.
The 鈥淣itric Oxide Therapy Device Industry Forecast鈥� looks at past sales and reviews total world Nitric Oxide Therapy Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Nitric Oxide Therapy Device sales for 2025 through 2031. With Nitric Oxide Therapy Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nitric Oxide Therapy Device industry.
This Insight Report provides a comprehensive analysis of the global Nitric Oxide Therapy Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nitric Oxide Therapy Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Nitric Oxide Therapy Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nitric Oxide Therapy Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nitric Oxide Therapy Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Nitric Oxide Therapy Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Fixed
Portable
Segmentation by Application:
Hospital
Rehabilitation Center
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Mallinckrodt
Praxair
Air Liquide
Beyond Air
Bellerophon Therapeutics
VERO Biotech
Third Pole
Key Questions Addressed in this Report
What is the 10-year outlook for the global Nitric Oxide Therapy Device market?
What factors are driving Nitric Oxide Therapy Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nitric Oxide Therapy Device market opportunities vary by end market size?
How does Nitric Oxide Therapy Device break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Nitric Oxide Therapy Device Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Nitric Oxide Therapy Device by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Nitric Oxide Therapy Device by Country/Region, 2020, 2024 & 2031
2.2 Nitric Oxide Therapy Device Segment by Type
2.2.1 Fixed
2.2.2 Portable
2.3 Nitric Oxide Therapy Device Sales by Type
2.3.1 Global Nitric Oxide Therapy Device Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Nitric Oxide Therapy Device Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Nitric Oxide Therapy Device Sale Price by Type (2020-2025)
2.4 Nitric Oxide Therapy Device Segment by Application
2.4.1 Hospital
2.4.2 Rehabilitation Center
2.4.3 Others
2.5 Nitric Oxide Therapy Device Sales by Application
2.5.1 Global Nitric Oxide Therapy Device Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Nitric Oxide Therapy Device Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Nitric Oxide Therapy Device Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Nitric Oxide Therapy Device Breakdown Data by Company
3.1.1 Global Nitric Oxide Therapy Device Annual Sales by Company (2020-2025)
3.1.2 Global Nitric Oxide Therapy Device Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Nitric Oxide Therapy Device Annual Revenue by Company (2020-2025)
3.2.1 Global Nitric Oxide Therapy Device Revenue by Company (2020-2025)
3.2.2 Global Nitric Oxide Therapy Device Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Nitric Oxide Therapy Device Sale Price by Company
3.4 Key Manufacturers Nitric Oxide Therapy Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nitric Oxide Therapy Device Product Location Distribution
3.4.2 Players Nitric Oxide Therapy Device Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Nitric Oxide Therapy Device by Geographic Region
4.1 World Historic Nitric Oxide Therapy Device 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Nitric Oxide Therapy Device Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Nitric Oxide Therapy Device Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Nitric Oxide Therapy Device 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Nitric Oxide Therapy Device Annual Sales by Country/Region (2020-2025)
4.2.2 Global Nitric Oxide Therapy Device Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nitric Oxide Therapy Device Sales Growth
4.4 APAC Nitric Oxide Therapy Device Sales Growth
4.5 Europe Nitric Oxide Therapy Device Sales Growth
4.6 Middle East & Africa Nitric Oxide Therapy Device Sales Growth
5 Americas
5.1 Americas Nitric Oxide Therapy Device Sales by Country
5.1.1 Americas Nitric Oxide Therapy Device Sales by Country (2020-2025)
5.1.2 Americas Nitric Oxide Therapy Device Revenue by Country (2020-2025)
5.2 Americas Nitric Oxide Therapy Device Sales by Type (2020-2025)
5.3 Americas Nitric Oxide Therapy Device Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nitric Oxide Therapy Device Sales by Region
6.1.1 APAC Nitric Oxide Therapy Device Sales by Region (2020-2025)
6.1.2 APAC Nitric Oxide Therapy Device Revenue by Region (2020-2025)
6.2 APAC Nitric Oxide Therapy Device Sales by Type (2020-2025)
6.3 APAC Nitric Oxide Therapy Device Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nitric Oxide Therapy Device by Country
7.1.1 Europe Nitric Oxide Therapy Device Sales by Country (2020-2025)
7.1.2 Europe Nitric Oxide Therapy Device Revenue by Country (2020-2025)
7.2 Europe Nitric Oxide Therapy Device Sales by Type (2020-2025)
7.3 Europe Nitric Oxide Therapy Device Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nitric Oxide Therapy Device by Country
8.1.1 Middle East & Africa Nitric Oxide Therapy Device Sales by Country (2020-2025)
8.1.2 Middle East & Africa Nitric Oxide Therapy Device Revenue by Country (2020-2025)
8.2 Middle East & Africa Nitric Oxide Therapy Device Sales by Type (2020-2025)
8.3 Middle East & Africa Nitric Oxide Therapy Device Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nitric Oxide Therapy Device
10.3 Manufacturing Process Analysis of Nitric Oxide Therapy Device
10.4 Industry Chain Structure of Nitric Oxide Therapy Device
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nitric Oxide Therapy Device Distributors
11.3 Nitric Oxide Therapy Device Customer
12 World Forecast Review for Nitric Oxide Therapy Device by Geographic Region
12.1 Global Nitric Oxide Therapy Device 麻豆原创 Size Forecast by Region
12.1.1 Global Nitric Oxide Therapy Device Forecast by Region (2026-2031)
12.1.2 Global Nitric Oxide Therapy Device Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Nitric Oxide Therapy Device Forecast by Type (2026-2031)
12.7 Global Nitric Oxide Therapy Device Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Mallinckrodt
13.1.1 Mallinckrodt Company Information
13.1.2 Mallinckrodt Nitric Oxide Therapy Device Product Portfolios and Specifications
13.1.3 Mallinckrodt Nitric Oxide Therapy Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Mallinckrodt Main Business Overview
13.1.5 Mallinckrodt Latest Developments
13.2 Praxair
13.2.1 Praxair Company Information
13.2.2 Praxair Nitric Oxide Therapy Device Product Portfolios and Specifications
13.2.3 Praxair Nitric Oxide Therapy Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Praxair Main Business Overview
13.2.5 Praxair Latest Developments
13.3 Air Liquide
13.3.1 Air Liquide Company Information
13.3.2 Air Liquide Nitric Oxide Therapy Device Product Portfolios and Specifications
13.3.3 Air Liquide Nitric Oxide Therapy Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Air Liquide Main Business Overview
13.3.5 Air Liquide Latest Developments
13.4 Beyond Air
13.4.1 Beyond Air Company Information
13.4.2 Beyond Air Nitric Oxide Therapy Device Product Portfolios and Specifications
13.4.3 Beyond Air Nitric Oxide Therapy Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Beyond Air Main Business Overview
13.4.5 Beyond Air Latest Developments
13.5 Bellerophon Therapeutics
13.5.1 Bellerophon Therapeutics Company Information
13.5.2 Bellerophon Therapeutics Nitric Oxide Therapy Device Product Portfolios and Specifications
13.5.3 Bellerophon Therapeutics Nitric Oxide Therapy Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Bellerophon Therapeutics Main Business Overview
13.5.5 Bellerophon Therapeutics Latest Developments
13.6 VERO Biotech
13.6.1 VERO Biotech Company Information
13.6.2 VERO Biotech Nitric Oxide Therapy Device Product Portfolios and Specifications
13.6.3 VERO Biotech Nitric Oxide Therapy Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 VERO Biotech Main Business Overview
13.6.5 VERO Biotech Latest Developments
13.7 Third Pole
13.7.1 Third Pole Company Information
13.7.2 Third Pole Nitric Oxide Therapy Device Product Portfolios and Specifications
13.7.3 Third Pole Nitric Oxide Therapy Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Third Pole Main Business Overview
13.7.5 Third Pole Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.